These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11219327)
21. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia. Heydorn WE Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714 [TBL] [Abstract][Full Text] [Related]
22. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Drover DR Clin Pharmacokinet; 2004; 43(4):227-38. PubMed ID: 15005637 [TBL] [Abstract][Full Text] [Related]
23. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)]. Ansseau M Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901 [TBL] [Abstract][Full Text] [Related]
25. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Terzano MG; Rossi M; Palomba V; Smerieri A; Parrino L Drug Saf; 2003; 26(4):261-82. PubMed ID: 12608888 [TBL] [Abstract][Full Text] [Related]
26. A NICE missed opportunity? Lader M J Psychopharmacol; 2005 Mar; 19(2):136-8. PubMed ID: 15728434 [No Abstract] [Full Text] [Related]
27. Zaleplon for insomnia. Med Lett Drugs Ther; 1999 Oct; 41(1063):93-4. PubMed ID: 10535052 [No Abstract] [Full Text] [Related]
28. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Holm KJ; Goa KL Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040 [TBL] [Abstract][Full Text] [Related]
29. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. Sanger DJ CNS Drugs; 2004; 18 Suppl 1():9-15; discussion 41, 43-5. PubMed ID: 15291009 [TBL] [Abstract][Full Text] [Related]
30. Reintroduction of quazepam: an update on comparative hypnotic and adverse effects. Moniri NH Int Clin Psychopharmacol; 2019 Nov; 34(6):275-285. PubMed ID: 31274695 [TBL] [Abstract][Full Text] [Related]
31. Short-term treatment with hypnotic drugs for insomnia: going beyond the evidence. Baldwin D J Psychopharmacol; 2005 Mar; 19(2):134-5. PubMed ID: 15728433 [No Abstract] [Full Text] [Related]
32. Management of insomnia--the role of zaleplon. Richardson GS; Roth T; Kramer JA MedGenMed; 2002 Mar; 4(1):9. PubMed ID: 11965211 [TBL] [Abstract][Full Text] [Related]
33. Main neuroendocrine features and therapy in primary sleep troubles. Amihăesei IC; Mungiu OC Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543 [TBL] [Abstract][Full Text] [Related]
34. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323 [TBL] [Abstract][Full Text] [Related]
35. The relationship between psychiatric diseases and insomnia. Roth T Int J Clin Pract Suppl; 2001 Jan; (116):3-8. PubMed ID: 11219330 [TBL] [Abstract][Full Text] [Related]
37. Individualizing therapy for early, middle-of-the-night and late-night insomnia. Scharf MB Int J Clin Pract Suppl; 2001 Jan; (116):20-4. PubMed ID: 11219329 [TBL] [Abstract][Full Text] [Related]
38. Greater incidence of depression with hypnotic use than with placebo. Kripke DF BMC Psychiatry; 2007 Aug; 7():42. PubMed ID: 17711589 [TBL] [Abstract][Full Text] [Related]
39. Methods for the analysis of nonbenzodiazepine hypnotic drugs in biological matrices. Tonon MA; Bonato PS Bioanalysis; 2012 Feb; 4(3):291-304. PubMed ID: 22303833 [TBL] [Abstract][Full Text] [Related]
40. [How well do Z-substances help in insomnia?]. Baier PC MMW Fortschr Med; 2013 Jun; 155(12):30. PubMed ID: 23923306 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]